较高的邻居贫困与行为变异前退行症的加速疾病进展有关
Rory Boyle1, Nadia Dehghani1, Sheina Emrani1
1Penn Frontotemporal Degeneration Center, Department of Neurology, Perelman School of Medicine, University of Pennsylvania, 3400 Spruce St, Philadelphia, PA 19104, USA.
medRxiv : the preprint server for health sciences
|June 4, 2025
概括
邻居剥夺显著缩短了生存时间,并加速了行为变异前退行症 (bvFTD) 的认知衰退. 这凸显了影响bvFTD疾病进展和预后的社会经济差异.
科学领域:
- 神经科学是一个神经科学.
- 公共卫生 公共卫生
- 老年学是一门学科.
背景情况:
- 社区贫困与较差的健康结果有关,包括老龄化和阿尔茨海默病.
- 社区贫困对行为变异前退行症 (bvFTD) 进展的影响仍未研究.
研究的目的:
- 调查社区贫困与bvFTD疾病进展之间的关联.
- 确定社会经济因素是否影响bvFTD患者的生存率和认知衰退.
主要方法:
- 利用区域贫困指数 (ADI) 分类社区贫困.
- 在311名bvFTD患者的研究生存率和纵向认知变化,基于ADI三位数.
- 在161名患者的小组中评估了全球认知,执行功能和语言.
主要成果:
- 在最贫困社区的个人在出现症状后的生存时间显著缩短.
- 在更贫困地区,全球认知,执行功能和语言的下降速度更快.
- 这些关联是独立于遗传风险因素而存在的.
结论:
- 邻居的剥夺与bvFTD的加速疾病过程有关.
- 社会经济差异显著影响bvFTD的预后.
- 调查结果强调需要在FTD护理和研究中解决社会经济因素.
相关概念视频
Parkinson's Disease: Overview
1.8K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
1.8K
Alzheimer's Disease: Overview
1.6K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.6K
Tumor Progression
7.2K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.2K
Neural Regulation
43.2K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
43.2K
Human Genetics
1.5K
Human genetics provides a profound framework for understanding the interplay between genetic predispositions and human psychology. At the heart of this discipline lies the study of how genes influence physical traits, behaviors, and susceptibility to diseases. Each person carries a unique genetic code that subtly or significantly shapes their psychological and behavioral landscape.
The complex relationship between genetics and psychology is observable through common biological components such...
The complex relationship between genetics and psychology is observable through common biological components such...
1.5K
Alzheimer's Disease: Treatment
827
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
827


